Program highlights
From global to local (and back again): Updates and Learnings from Our Country Pilot Program
We are excited to share some progress and insights from our Country Pilot Program, which continues to foster collaboration among local stakeholders across Spain, Hungary, and just recently in the Philippines and Japan.
New tool for HCPs aims to decode complex results in precision oncology
At the crux of patient-centered care is effective and meaningful communication between the relevant healthcare professional and the patient. This is especially crucial in the area of personalized healthcare. A distinct shift has taken place, moving away from the paternalistic model of medicine to a new approach of shared decision-making regarding treatment regimes that are truly tailored to the patient.
Now published
Our latest literature review dives into best practices and hurdles in communication between patients and providers regarding biomarker testing in precision oncology.
About us
Our motivation
All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.
Our ambition
Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.
The partnership
We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.
Members
